Description
| COMPOSITION: | Each uncoated Sustained release tablet contains Vildagliptin 100 mg |
| FORMULATION: | test |
| STATUS: | PRESCRIPTION ONLY DRUG |
| DESCRIPTION: | Debiglip tablet contains Vildagliptin, a new class of anti-diabetics that acts on the intestinal enzyme to control diabetes. It is prescribed in adjunct to diet control, exercise & other drugs to control type II diabetes. |
| SIDE EFFECTS: | The main side effects are hypoglycemia (in combination with other drugs), tremor, dizziness, headache and Nausea. |
| DOSAGE/DIRECTIONS FOR USE: | As Prescribed by Physician |
Reviews
There are no reviews yet.